Narinder Pal Bhalla - 20 Jan 2026 Form 3 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Signature
/s/ Youjin Choi, Attorney-in-Fact
Issuer symbol
LXEO
Transactions as of
20 Jan 2026
Net transactions value
$0
Form type
3
Filing time
05 Feb 2026, 16:45:20 UTC
Next filing
17 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bhalla Narinder Pal Chief Medical Officer C/O LEXEO THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, 6TH FLOOR, NEW YORK /s/ Youjin Choi, Attorney-in-Fact 05 Feb 2026 0002109299

No securities are beneficially owned.